Vaccines

Papers
(The H4-Index of Vaccines is 80. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
COVID-19 Vaccine Hesitancy Worldwide: A Concise Systematic Review of Vaccine Acceptance Rates1058
Confidence and Receptivity for COVID-19 Vaccines: A Rapid Systematic Review547
Factors Associated with COVID-19 Vaccine Hesitancy476
High Rates of COVID-19 Vaccine Hesitancy and Its Association with Conspiracy Beliefs: A Study in Jordan and Kuwait among Other Arab Countries453
Vaccine Knowledge, Awareness and Hesitancy: A Cross Sectional Survey among Parents Residing at Sandakan District, Sabah353
Nanomaterial Delivery Systems for mRNA Vaccines342
COVID-19 Vaccine Acceptance among Health Care Workers in the United States329
COVID-19 Vaccine Hesitancy—A Scoping Review of Literature in High-Income Countries308
Lack of Trust, Conspiracy Beliefs, and Social Media Use Predict COVID-19 Vaccine Hesitancy289
Immune-Mediated Disease Flares or New-Onset Disease in 27 Subjects Following mRNA/DNA SARS-CoV-2 Vaccination287
Lipid-Based Nanoparticles in the Clinic and Clinical Trials: From Cancer Nanomedicine to COVID-19 Vaccines271
Factors Affecting COVID-19 Vaccine Acceptance: An International Survey among Low- and Middle-Income Countries219
Willingness to Receive COVID-19 Vaccination in Japan206
Acceptance of a COVID-19 Vaccine in Japan during the COVID-19 Pandemic204
Emerging SARS-CoV-2 Variants and Impact in Global Vaccination Programs against SARS-CoV-2/COVID-19203
Change of Willingness to Accept COVID-19 Vaccine and Reasons of Vaccine Hesitancy of Working People at Different Waves of Local Epidemic in Hong Kong, China: Repeated Cross-Sectional Surveys194
Efficacy and Safety of COVID-19 Vaccines: A Systematic Review and Meta-Analysis of Randomized Clinical Trials193
Challenges of Storage and Stability of mRNA-Based COVID-19 Vaccines187
SARS-CoV-2 mRNA Vaccines: Immunological Mechanism and Beyond178
Role of Inflammatory Cytokines in COVID-19 Patients: A Review on Molecular Mechanisms, Immune Functions, Immunopathology and Immunomodulatory Drugs to Counter Cytokine Storm154
Side Effects and Perceptions Following COVID-19 Vaccination in Jordan: A Randomized, Cross-Sectional Study Implementing Machine Learning for Predicting Severity of Side Effects146
An Update on Self-Amplifying mRNA Vaccine Development139
A Scoping Review to Find Out Worldwide COVID-19 Vaccine Hesitancy and Its Underlying Determinants133
Allergic Reactions to Current Available COVID-19 Vaccinations: Pathophysiology, Causality, and Therapeutic Considerations131
The Changing Acceptance of COVID-19 Vaccination in Different Epidemic Phases in China: A Longitudinal Study129
Willingness to Receive the Booster COVID-19 Vaccine Dose in Poland126
The Health Belief Model Applied to COVID-19 Vaccine Hesitancy: A Systematic Review124
Post-COVID Syndrome: An Insight on Its Pathogenesis122
Worldwide Vaccination Willingness for COVID-19: A Systematic Review and Meta-Analysis119
Assessing Acceptability of COVID-19 Vaccine Booster Dose among Adult Americans: A Cross-Sectional Study118
COVID-19 Vaccine Hesitancy and Its Associated Factors in Japan116
Global COVID-19 Vaccine Acceptance: A Systematic Review of Associated Social and Behavioral Factors114
COVID-19 Vaccination Hesitancy among Healthcare Workers—A Review113
Enhancing COVID-19 Vaccines Acceptance: Results from a Survey on Vaccine Hesitancy in Northern Italy113
COVID-19 Vaccine Roll-Out in South Africa and Zimbabwe: Urgent Need to Address Community Preparedness, Fears and Hesitancy110
Immune Responses Induced by mRNA Vaccination in Mice, Monkeys and Humans107
COVID-19 Vaccine Hesitancy and Resistance in India Explored through a Population-Based Longitudinal Survey106
Attitude and Behaviors towards SARS-CoV-2 Vaccination among Healthcare Workers: A Cross-Sectional Study from Poland105
COVID-19 Vaccine Hesitancy and Attitude toward Booster Doses among US Healthcare Workers105
Would Parents Get Their Children Vaccinated Against SARS-CoV-2? Rate and Predictors of Vaccine Hesitancy According to a Survey over 5000 Families from Bologna, Italy104
Predictors of COVID-19 Vaccine Hesitancy: Socio-Demographics, Co-Morbidity, and Past Experience of Racial Discrimination104
The Strategies to Support the COVID-19 Vaccination with Evidence-Based Communication and Tackling Misinformation104
Evaluation of Side Effects Associated with COVID-19 Vaccines in Saudi Arabia104
Detailed Dissection and Critical Evaluation of the Pfizer/BioNTech and Moderna mRNA Vaccines103
COVID-19 Vaccine Acceptance among Low- and Lower-Middle-Income Countries: A Rapid Systematic Review and Meta-Analysis103
Psychological Determinants of COVID-19 Vaccine Acceptance among Healthcare Workers in Kuwait: A Cross-Sectional Study Using the 5C and Vaccine Conspiracy Beliefs Scales102
Medical Students and SARS-CoV-2 Vaccination: Attitude and Behaviors101
COVID-19 Vaccine Acceptance in the Democratic Republic of Congo: A Cross-Sectional Survey100
Comparison of Four SARS-CoV-2 Neutralization Assays100
Human Papillomavirus Vaccine Efficacy and Effectiveness against Cancer99
Neutralizing Activity of Sera from Sputnik V-Vaccinated People against Variants of Concern (VOC: B.1.1.7, B.1.351, P.1, B.1.617.2, B.1.617.3) and Moscow Endemic SARS-CoV-2 Variants98
An Overview of Vaccine Adjuvants: Current Evidence and Future Perspectives98
Assessment of Vaccine Hesitancy to a COVID-19 Vaccine in Cameroonian Adults and Its Global Implication97
Emerging SARS-CoV-2 Variants: A Review of Its Mutations, Its Implications and Vaccine Efficacy97
Vaccine Hesitancy on Social Media: Sentiment Analysis from June 2011 to April 201997
Flattening the Curve of COVID-19 Vaccine Rejection—An International Overview96
Efforts at COVID-19 Vaccine Development: Challenges and Successes93
Examining Vaccine Hesitancy in Sub-Saharan Africa: A Survey of the Knowledge and Attitudes among Adults to Receive COVID-19 Vaccines in Ghana93
Reactivation of Varicella Zoster Virus after Vaccination for SARS-CoV-293
Motivation to Have COVID-19 Vaccination Explained Using an Extended Protection Motivation Theory among University Students in China: The Role of Information Sources93
The Perception and Attitudes toward COVID-19 Vaccines: A Cross-Sectional Study in Poland92
Acceptability of COVID-19 Vaccination among Greek Health Professionals91
Side Effects Reported by Jordanian Healthcare Workers Who Received COVID-19 Vaccines90
Occurrence of Antibodies against SARS-CoV-2 in the Domestic Cat Population of Germany90
Safety and Efficacy of COVID-19 Vaccines: A Systematic Review and Meta-Analysis of Different Vaccines at Phase 389
Factors Influencing Public Attitudes towards COVID-19 Vaccination: A Scoping Review Informed by the Socio-Ecological Model89
COVID-19 Vaccine Booster Hesitancy (VBH) of Healthcare Workers in Czechia: National Cross-Sectional Study89
Current Advances of Nitric Oxide in Cancer and Anticancer Therapeutics88
Percentage of Asymptomatic Infections among SARS-CoV-2 Omicron Variant-Positive Individuals: A Systematic Review and Meta-Analysis88
COVID-19 Vaccine Acceptance, Hesitancy, and Resistancy among University Students in France88
Knowledge and Acceptance of COVID-19 Vaccination among Undergraduate Students from Central and Southern Italy86
An Updated Review of SARS-CoV-2 Vaccines and the Importance of Effective Vaccination Programs in Pandemic Times86
Review: Vaccines and Vaccination against Lumpy Skin Disease86
Attitudes and Beliefs on Influenza Vaccination during the COVID-19 Pandemic: Results from a Representative Italian Survey86
Varicella Zoster Virus Reactivation Following COVID-19 Vaccination: A Systematic Review of Case Reports86
Acceptability of a COVID-19 Vaccine among the Saudi Population86
Global Prevalence and Potential Influencing Factors of COVID-19 Vaccination Hesitancy: A Meta-Analysis82
Resources, Production Scales and Time Required for Producing RNA Vaccines for the Global Pandemic Demand80
Large-Scale Study of Antibody Titer Decay following BNT162b2 mRNA Vaccine or SARS-CoV-2 Infection80
Pruritus as a Distinctive Feature of Type 2 Inflammation80
0.1204822063446